This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grüber, C.
Right arrow Articles by the MAS-90 Study Group
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grüber, C.
Right arrow Articles by the MAS-90 Study Group,
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 107 No. 3 March 2001, p. e36

ELECTRONIC ARTICLE:
Delayed Hypersensitivity to Tuberculin, Total Immunoglobulin E, Specific Sensitization, and Atopic Manifestation in Longitudinally Followed Early Bacille Calmette-Guérin-Vaccinated and Nonvaccinated Children

Received Jul 18, 2000; accepted Oct 18, 2000.

Christoph Grüber*, Michael KuligDagger , Renate Bergmann*, Irene Guggenmoos-Holzmann, Dagger , Ulrich Wahn*, and the MAS-90 Study Group

From * Children's Hospital, Charité Campus Virchow, Medical Faculty of Humboldt Universität; and the Dagger  Institute of Medical Statistics, Klinikum Benjamin Franklin, Freie Universität, Berlin, Germany.

Background.  Bacille Calmette-Guérin (BCG) is a strong T helper 1 incentive and, thus, may contribute to a decreased risk of T helper 2-dependent atopic disease.

Objective.  To investigate the natural course of specific immunoglobulin E (IgE) responses and atopic disease in BCG-vaccinated and nonvaccinated children.

Participants.  Seven hundred seventy-four children from a prospectively followed birth cohort.

Outcome Measures.  Physical examination and case history were performed at 3, 6, 12, 18, 24, 36, 48, 60, 72, and 84 months of age. Total and specific serum IgE levels to 9 common inhalant and food allergens were determined (CAP; Pharmacia, Freiburg, Germany) at 12, 24, 36, 60, 72, and 84 months of age. Purified protein derivative (PPD) skin testing was performed at 84 months.

Results.  Period and lifetime prevalences of atopic dermatitis and recurrent wheezing tended to be lower in the BCG-vaccinated group early in life, whereas no such trend was found after the second birthday or for allergic rhinitis. The proportion of children remaining free of clinical manifestations tended to be higher in the BCG-vaccinated group but differences decreased over time. No statistically significant differences were found for total IgE levels (median). Atopic sensitization tended to be lower among BCG-vaccinated children during the first 2 years of life. The diameter of the skin reaction to PPD did not correlate with total serum IgE. Clinical and serologic correlates of atopy were not significantly different between children with a skin test diameter of >= 5 mm and those with a smaller diameter.

Conclusion.  These results do not support the hypothesis that BCG vaccination in early infancy is associated with a subsequently markedly decreased risk of atopic sensitization or allergy. In addition, PPD skin test reactivity was not impaired in atopic individuals.  Key words:  Bacille Calmette-Guérin, atopy, total immunoglobulin E, allergic sensitization, allergy prevention, delayed type hypersensitivity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ThoraxHome page
K. Nakajima, S. C Dharmage, J. B Carlin, C. L Wharton, M. A Jenkins, G. G Giles, M. J Abramson, E Haydn Walters, and J. L Hopper
Is childhood immunisation associated with atopic disease from age 7 to 32 years?
Thorax, March 1, 2007; 62(3): 270 - 275.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
S A Bremner, I M Carey, S DeWilde, N Richards, W C Maier, S R Hilton, D P Strachan, and D G Cook
Timing of routine immunisations and subsequent hay fever risk
Arch. Dis. Child., June 1, 2005; 90(6): 567 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Gruber, S. Lau, A. Dannemann, C. Sommerfeld, U. Wahn, and R. C. Aalberse
Down-Regulation of IgE and IgG4 Antibodies to Tetanus Toxoid and Diphtheria Toxoid by Covaccination with Cellular Bordetella pertussis Vaccine
J. Immunol., August 15, 2001; 167(4): 2411 - 2417.
[Abstract] [Full Text] [PDF]